Insider Selling: Cardlytics, Inc. (NASDAQ:CDLX) COO Sells 23,416 Shares of Stock

Cardlytics, Inc. (NASDAQ:CDLX) COO Amit Gupta sold 23,416 shares of the stock in a transaction that occurred on Wednesday, April 24th. The stock was sold at an average price of $11.91, for a total transaction of $278,884.56. Following the transaction, the chief operating officer now owns 122,676 shares in the company, valued at approximately $1,461,071.16. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Cardlytics Stock Performance

NASDAQ CDLX opened at $11.52 on Thursday. The company has a current ratio of 1.31, a quick ratio of 1.31 and a debt-to-equity ratio of 1.91. The firm has a market capitalization of $554.96 million, a price-to-earnings ratio of -3.33 and a beta of 1.44. The firm’s 50 day simple moving average is $11.10 and its 200 day simple moving average is $9.64. Cardlytics, Inc. has a 1 year low of $4.94 and a 1 year high of $20.52.

Cardlytics (NASDAQ:CDLX) last posted its quarterly earnings results on Thursday, March 14th. The company reported ($0.14) earnings per share (EPS) for the quarter. The firm had revenue of $89.17 million for the quarter. Cardlytics had a negative return on equity of 25.38% and a negative net margin of 43.56%.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on CDLX shares. Lake Street Capital increased their target price on shares of Cardlytics from $13.00 to $18.00 and gave the stock a “buy” rating in a research report on Friday, March 15th. Needham & Company LLC increased their target price on shares of Cardlytics from $15.00 to $17.00 and gave the stock a “buy” rating in a research report on Tuesday, April 9th. Finally, Craig Hallum upgraded shares of Cardlytics from a “hold” rating to a “buy” rating and increased their target price for the stock from $10.00 to $18.00 in a research report on Friday, March 15th.

Institutional Trading of Cardlytics

Several large investors have recently made changes to their positions in CDLX. Deutsche Bank AG lifted its stake in Cardlytics by 5.0% in the 3rd quarter. Deutsche Bank AG now owns 43,992 shares of the company’s stock valued at $726,000 after purchasing an additional 2,093 shares during the last quarter. Check Capital Management Inc. CA lifted its stake in Cardlytics by 14.0% in the 4th quarter. Check Capital Management Inc. CA now owns 23,200 shares of the company’s stock valued at $214,000 after purchasing an additional 2,850 shares during the last quarter. Brown Advisory Inc. lifted its stake in Cardlytics by 1.7% in the 4th quarter. Brown Advisory Inc. now owns 199,633 shares of the company’s stock valued at $1,839,000 after purchasing an additional 3,257 shares during the last quarter. SG Americas Securities LLC lifted its stake in Cardlytics by 34.3% in the 4th quarter. SG Americas Securities LLC now owns 21,461 shares of the company’s stock valued at $198,000 after purchasing an additional 5,484 shares during the last quarter. Finally, Tower Research Capital LLC TRC lifted its stake in Cardlytics by 349.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 9,602 shares of the company’s stock valued at $88,000 after purchasing an additional 7,465 shares during the last quarter. Institutional investors and hedge funds own 68.10% of the company’s stock.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.